Who
Hunter R. Murdock
General Counsel
Company insider
Files Form 4 as: General Counsel, Axsome Therapeutics.
In numbers
- Trades disclosed
- 26
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $3.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Mar 2023
- Last trade
- 21 Apr 2026
- Last filed
- 23 Apr 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Apr 2026filed 23 Apr 2026 | AXSM Axsome Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,224 at $0.00 | filing |
| 21 Apr 2026filed 23 Apr 2026 | AXSM Axsome Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,224 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | AXSM Axsome Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,385 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | AXSM Axsome Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,385 at $0.00 | filing |
| 23 Jun 2025filed 23 Jun 2025 | AXSM Axsome Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,014 at $0.00 | filing |
| 23 Jun 2025filed 23 Jun 2025 | AXSM Axsome TherapeuticsBiotechnology | SEC FORM 4 Code M | $180K6,014 at $29.91 | filing |
| 23 Jun 2025filed 23 Jun 2025 | AXSM Axsome TherapeuticsBiotechnology | SEC FORM 4 Sold | $602K6,014 at $100.12 | filing |
| 20 Jun 2025filed 23 Jun 2025 | AXSM Axsome Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 20 Jun 2025filed 23 Jun 2025 | AXSM Axsome TherapeuticsBiotechnology | SEC FORM 4 Code M | $224K7,500 at $29.91 | filing |
| 20 Jun 2025filed 23 Jun 2025 | AXSM Axsome TherapeuticsBiotechnology | SEC FORM 4 Sold | $769K7,500 at $102.47 | filing |
| 18 Jun 2025filed 18 Jun 2025 | AXSM Axsome Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 18 Jun 2025filed 18 Jun 2025 | AXSM Axsome TherapeuticsBiotechnology | SEC FORM 4 Code M | $224K7,500 at $29.91 | filing |
| 18 Jun 2025filed 18 Jun 2025 | AXSM Axsome TherapeuticsBiotechnology | SEC FORM 4 Sold | $757K7,500 at $100.90 | filing |
| 17 Jun 2025filed 18 Jun 2025 | AXSM Axsome Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 17 Jun 2025filed 18 Jun 2025 | AXSM Axsome TherapeuticsBiotechnology | SEC FORM 4 Code M | $224K7,500 at $29.91 | filing |
| 17 Jun 2025filed 18 Jun 2025 | AXSM Axsome TherapeuticsBiotechnology | SEC FORM 4 Sold | $752K7,500 at $100.26 | filing |
| 16 Jun 2025filed 18 Jun 2025 | AXSM Axsome Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 16 Jun 2025filed 18 Jun 2025 | AXSM Axsome TherapeuticsBiotechnology | SEC FORM 4 Code M | $224K7,500 at $29.91 | filing |
| 16 Jun 2025filed 18 Jun 2025 | AXSM Axsome TherapeuticsBiotechnology | SEC FORM 4 Sold | $768K7,500 at $102.42 | filing |
| 24 Feb 2025filed 25 Feb 2025 | AXSM Axsome Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,740 at $0.00 | filing |
News
Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?AXSM · fool.com · 8 Oct 2026
0 headlines in the last 90 days name Hunter R. Murdock; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.